Use of Systemic Hormone Therapy After Age 65 - North American Menopause Society

medscape

....Provided that the woman has been advised of the increase in risks associated with continuing HT beyond age 60 and has clinical supervision, extending HT use with the lowest effective dose is acceptable under some circumstances, such as for the woman who has persistent bothersome menopausal symptoms and for whom her clinician has determined that the benefits of menopause symptom relief outweigh the risks. Use of HT should be individualized and not discontinued solely based on a woman's age.^[5] The decision to continue or discontinue HT should be made jointly by the woman and her healthcare provider.

 References

1. The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause 2012;19:257-271.
2. Avis NE, Crawford SL, Greendale G, et al; Study of Women's Health Across the Nation (SWAN). Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med 2015;175:531-539.
3. Gartoulla P, Worsley R, Bell RJ, Davis SR. Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years. Menopause 2015;22:XXX-XXX.
4. Kaunitz AM. Extended duration use of menopausal hormone therapy. Menopause 2014;21:679-681.
5. ACOG Practice Bulletin No. 141: management of menopausal symptoms. Obstet Gynecol 2014;123:202-216.